Ronald R. Grunstein

May 17, 2024

Evaluating possible ‘next day’ impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial

Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s00213-024-06595-9. Article type: Research Article Keywords: cannabinoids, cognition, driving…

February 27, 2024

Detection of Δ9‐tetrahydrocannabinol (THC) in oral fluid using two point‐of‐collection testing devices following oral administration of a THC and cannabidiol containing oil

Abstract Point‐of‐collection testing (POCT) devices are widely used in roadside and workplace drug testing to identify recent cannabis use by…

August 30, 2021

Orally administered cannabidiol does not produce false‐positive tests for Δ9‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000

Abstract Many jurisdictions use point‐of‐collection (POC) oral fluid testing devices to identify driving under the influence of cannabis, indexed by…